Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

Article  CAS  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34. https://doi.org/10.3322/caac.21551

Andreozzi A, Brunese L, Iasiello M, Tucci C, Vanoli GP (2019) Modeling heat transfer in tumors: a review of Thermal therapies. Ann Biomed Eng 47(3):676–693. https://doi.org/10.1007/s10439-018-02177-x

Article  PubMed  Google Scholar 

Singh PK, Tiwari AK, Rajmani RS et al (2015) Apoptin as a potential viral gene Oncotherapeutic Agent. Appl Biochem Biotechnol 176(1):196–212. https://doi.org/10.1007/s12010-015-1567-5

Article  CAS  PubMed  Google Scholar 

Wang Y, Song X, Gao H et al (2017) C-terminal region of apoptin affects chicken anemia virus replication and virulence. Virol J 14(1):38. https://doi.org/10.1186/s12985-017-0713-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maddika S (2005) Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci 118(19):4485–4493. https://doi.org/10.1242/jcs.02580

Article  CAS  PubMed  Google Scholar 

Liu X, Elojeimy S, El-Zawahry AM et al (2006) Modulation of Ceramide Metabolism enhances viral protein apoptin’s cytotoxicity in prostate Cancer. Mol Ther 14(5):637–646. https://doi.org/10.1016/j.ymthe.2006.06.005

Article  CAS  PubMed  Google Scholar 

Malla WA, Arora R, Khan RIN, Mahajan S, Tiwari AK (2020) Apoptin as a Tumor-Specific Therapeutic Agent: current perspective on mechanism of Action and Delivery systems. Front Cell Dev Biol 8(June):1–15. https://doi.org/10.3389/fcell.2020.00524

Article  Google Scholar 

Wyatt J, Chan YK, Hess M, Tavassoli M, Müller MM (2023) Semisynthesis reveals apoptin as a tumour-selective protein prodrug that causes cytoskeletal collapse. Chem Sci 14(14):3881–3892. https://doi.org/10.1039/d2sc04481a

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu X, Wang T, Li Y et al (2023) Apoptin causes apoptosis in HepG-2 cells via Ca2 + imbalance and activation of the mitochondrial apoptotic pathway. Cancer Med 12(7):8306–8318. https://doi.org/10.1002/cam4.5528

Article  CAS  PubMed  Google Scholar 

Wagstaff K, Jans D (2006) Protein transduction: cell penetrating peptides and their therapeutic applications. Curr Med Chem 13(12):1371–1387. https://doi.org/10.2174/092986706776872871

Article  CAS  PubMed  Google Scholar 

Ruben S, Perkins A, Purcell R et al (1989) Structural and functional characterization of human immunodeficiency virus tat protein. J Virol 63(1):1–8. https://doi.org/10.1128/JVI.63.1.1-8.1989

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyu C, Fang F, Li B (2019) Anti-tumor effects of Melittin and its potential applications in clinic. Curr Protein Pept Sci 20(3):240–250. https://doi.org/10.2174/1389203719666180612084615

Article  CAS  PubMed  Google Scholar 

Rady I, Siddiqui IA, Rady M, Mukhtar H (2017) Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett 402:16–31. https://doi.org/10.1016/j.canlet.2017.05.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jamasbi E, Mularski A, Separovic F (2015) Model membrane and cell studies of antimicrobial activity of Melittin Analogues. Curr Top Med Chem 16(1):40–45. https://doi.org/10.2174/1568026615666150703115919

Article  CAS  Google Scholar 

Lv X, Zhang C, Shuaizhen Q, Yu R, Zheng Y (2020) Design of integrin αvβ3 targeting self-assembled protein nanoparticles with RGD peptide. Biomed Pharmacother 128(February):110236. https://doi.org/10.1016/j.biopha.2020.110236

Article  CAS  PubMed  Google Scholar 

Zhang C, Zhou D (2016) Adenoviral vector-based strategies against infectious disease and cancer. Hum Vaccin Immunother 12(8):2064–2074. https://doi.org/10.1080/21645515.2016.1165908

Article  PubMed  PubMed Central  Google Scholar 

Goradel NH, Baker AT, Arashkia A, Ebrahimi N, Ghorghanlu S, Negahdari B (2021) Oncolytic virotherapy: challenges and solutions. Curr Probl Cancer 45(1):100639. https://doi.org/10.1016/j.currproblcancer.2020.100639

Article  PubMed  Google Scholar 

Shalhout SZ, Miller DM, Emerick KS, Kaufman HL (2023) Therapy with oncolytic viruses: progress and challenges. Nat Rev Clin Oncol 20(3):160–177. https://doi.org/10.1038/s41571-022-00719-w

Article  PubMed  Google Scholar 

Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G (2021) Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther 6(1):53. https://doi.org/10.1038/s41392-021-00487-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu F-C, Li Y-H, Guan X-H et al (2020) Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 395(10240):1845–1854. https://doi.org/10.1016/S0140-6736(20)31208-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu F-C, Wurie AH, Hou L-H et al (2017) Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 389(10069):621–628. https://doi.org/10.1016/S0140-6736(16)32617-4

Article  CAS  PubMed  Google Scholar 

Zhou Y, Liu F, Li C et al (2018) Construction and characterization of Adenovirus vectors encoding Aspartate- β -Hydroxylase to preliminary application in Immunotherapy of Hepatocellular Carcinoma. J Immunol Res 2018:1–10. https://doi.org/10.1155/2018/9832467

Article  CAS  Google Scholar 

Zheng Y, Lu Z, Ding J et al (2022) Therapeutic Adenovirus Vaccine Combined immunization with IL-12 induces potent CD8 + T cell Anti-tumor Immunity in Hepatocellular Carcinoma. Cancers (Basel) 14(18):4512. https://doi.org/10.3390/cancers14184512

Article  CAS  PubMed  Google Scholar 

Chu T-H, Ko C-Y, Tai P-H et al (2022) Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma. J Biol Chem 298(10):102442. https://doi.org/10.1016/j.jbc.2022.102442

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z, Li Y, Zhu Y et al (2022) Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway. Int J Biol Sci 18(2):717–730. https://doi.org/10.7150/ijbs.64350

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Shang C, Liu Z et al (2022) Apoptin mediates mitophagy and endogenous apoptosis by regulating the level of ROS in hepatocellular carcinoma. Cell Commun Signal 20(1):1–15. https://doi.org/10.1186/s12964-022-00940-1

Article  CAS  Google Scholar 

Song G, Shang C, Zhu Y et al (2022) Apoptin inhibits glycolysis and regulates autophagy by targeting pyruvate kinase M2 (PKM2) in lung cancer A549 cells. Curr Cancer Drug Targets 23:1–14. https://doi.org/10.2174/1568009623666221025150239

Article  CAS  Google Scholar